The Strategist: Beatrix Szebeni-Varga
By
Our Expert on Quality and Regulatory Compliance
New Article in Major Journal Highlights Flaws in American Circumcision Policy
The need for transparency on non-medical factors in circumcision policy.
Healing the Harm, Restoring Wholeness
Insights From Our White Paper
November 1st, 2025
Rat trial results are published! Plus: Final safety testing is nearing completion in the lab
October 1st, 2025
Promising Biocompatibility Results
September 2nd, 2025
Foregen moves towards milestone 4, launches lab tour video, and seeks institutional funding.
March 3rd, 2025
Strong fundraising and new preclinical partnership!
February 1st, 2025
New Research Begins in Slovakia!
New Research Partnership with Dr. Stanislav Žiaran
Dr. Stanislav Žiaran in Bratislava, Slovakia
January 2nd, 2025
2024 Year-End Research & Development Update
December 1st, 2024
Planning for human trials
Tax Benefits of Crypto Donations to Foregen in 2024
Unlock significant tax advantages!
November 4th, 2024
Gainful progress towards our final goal
October 2nd, 2024
Foregen is preparing for human clinical trials
September 2nd, 2024
A successful meeting between our surgical consultant and the veterinarian team
.png)
.png)
Commentarium
by foregen